Nicholas Falzon and Margot Pisani, respectively president and secretary general at the Pharmaceutical Research-based Industry Malta Association (PRIMA), discuss the business environment for originators in the island as well as the efforts of the government to provide more innovative solutions to Maltese patients.
Can you please introduce yourself to our international audience as well as the main activities and priorities of the association in Malta?
"Market access is an issue in most European countries but in Malta it is even more visible due to a lack of medicine reimbursement that is present in the country"
